Metformin as Targeted Treatment in Fragile X Syndrome
Background Individuals with fragile X syndrome (FXS) have both behavioral and medical comorbidities and the latter include obesity in approximately 30% and the Prader‐Willi Phenotype (PWP) characterized by severe hyperphagia and morbid obesity in less than 10%. Metformin is a drug used in individual...
Saved in:
Main Authors: | Dy, Angel Belle C, Tassone, F, Eldeeb, M, Salcedo-Arellano, M.J, Tartaglia, N, Hagerman, R |
---|---|
Format: | text |
Published: |
Archīum Ateneo
2017
|
Subjects: | |
Online Access: | https://archium.ateneo.edu/asmph-pubs/23 https://onlinelibrary.wiley.com/doi/full/10.1111/cge.13039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Ateneo De Manila University |
Similar Items
-
Fragile X- associated Neuropsychiatric Disorders: A Case Report
by: Tan, Maria Melinda, et al.
Published: (2019) -
New Targeted Treatments for Fragile X Syndrome
by: Protic, Dragana, et al.
Published: (2019) -
A case of Noonan syndrome associated with nephrotic syndrome, pituitary mass and pes varus
by: Pacheco, Elizabeth Paz-, et al.
Published: (2013) -
Autism Symptoms in Fragile X Syndrome
by: Niu, Manman, et al.
Published: (2017) -
Molecular screening for fragile x syndrome in Thailand
by: Pornprot Limprasert, et al.
Published: (1999)